For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Public Health Association calls for the Minister of Health to intervene and support the Māori Health Authority alternative commissioning framework
Public Health Association calls for the Minister of Health to intervene and support the Māori Health Authority alternative commissioning framework

The Public Health Association of New Zealand (PHANZ) calls on the Minister of Health to intervene and adopt the alternative commissioning framework outlined on pg 174 of the Simpson Report.
To seriously address the intergenerational Māori health inequities highlighted in the WAI 2575 Hauora: Stage One report both the government, and the minister must entrench a commissioning/co commissioning role for the new Māori Health Authority.
We also call for answers on why a consensus on the alternative report could not be reached with the Māori Expert Advisory Panel from Heather Simpson, and for a full Te Tiriti compliance-based audit on the Health and Disability Review Report 2020
The PHA supports its member’s feedback with a full summary of recommendations that can be found here